Other Global Peers |
AGILENT TECHNOLOGIES INC (NYSE), INCYTE CORPORATION (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), SEATTLE GENETICS INC (NASDAQ), SINO BIOPHARM (HKEx), EXACT SCIENCES CORP (NASDAQ), WUXI BIO (HKEx), SAREPTA THERAPEUTICS INC (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), BEIGENE-B (HKEx), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), LOXO ONCOLOGY INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), TILRAY INC (NASDAQ), MODERNA INC (NASDAQ), EXELIXIS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALKERMES PLC (NASDAQ), ARRAY BIOPHARMA INC (NASDAQ), FIBROGEN INC (NASDAQ), 3SBIO (HKEx), ALLOGENE THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), GENSCRIPT BIO (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), BLUEPRINT MEDICINES CORP (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENOMIC HEALTH INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), REPLIGEN CORP (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), XENCOR INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), REGENXBIO INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), OPKO HEALTH INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), MYOVANT SCIENCES LTD (NYSE), AIMMUNE THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), UNIQURE N.V. (NASDAQ), VANDA PHARMACE INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), INTREXON CORP (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MACROGENICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), NATERA INC (NASDAQ), EPIZYME INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), ASCLETIS-B (HKEx), ALDER BIOPHARMACEUTICALS INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), RETROPHIN INC (NASDAQ), HAOHAI BIOTEC (HKEx), INFLARX N V (NASDAQ), IMMUNOGEN INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), NOVAVAX INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), ARVINAS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), VERACYTE INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), OMEROS CORP (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), SYNTHORX INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), PROTHENA CORP PLC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), CKLIFE SCIENCES (HKEx), GLYCOMIMETICS INC (NASDAQ), LEE'S PHARM (HKEx), PDL BIOPHARMA INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CYTOKINETICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), ESSEX BIO-TECH (HKEx), PROGENICS PHARMACEUTICALS INC (NASDAQ), MESOBLAST LTD (ASX), FIVE PRIME THERAPEUTICS (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), INSYS THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), POLYNOVO LIMITED (ASX), DERMIRA INC (NASDAQ), MEDICINOVA INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), XBIOTECH INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), RTI SURGICAL INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), SOLID BIOSCIENCES INC (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), GERON CORP (NASDAQ), KADMON HLDGS INC (NYSE), MERUS B V (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), TOCAGEN INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), VERASTEM INC (NASDAQ), SAVARA INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), SYNLOGIC INC (NASDAQ), KAMADA (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), RESTORBIO INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ATHERSYS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), IMV INC (NASDAQ), AFFIMED N V (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), AVITA MEDICAL LTD (ASX), RECRO PHARMA INC (NASDAQ), AXOVANT SCIENCES LTD (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), BBI LIFE SCI (HKEx), VBI VACCINES INC CDA (NASDAQ), CCMDBIO (Bursa), PIERIS PHARMACEUTICALS INC (NASDAQ), ENZO BIOCHEM INC (NYSE), ZAFGEN INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), ARDELYX INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), TREVENA INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), STANDARD DIVERSIFIED INC (NYSE American), NABRIVA THERAPEUTICS PLC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), COHBAR INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), XOMA CORP (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), PLURISTEM THERAPEUTICS INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), TELIX PHARMACEUTIC (ASX), EQUILLIUM INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), CHAMPIONS ONCOLOGY INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), CHIMERIX INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PFENEX INC (NYSE American), CHIASMA INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), UNI-BIO GROUP (HKEx), EDAP TMS S.A. ADS EACH REPR 1 ORD SHARE FRF0.8 (NASDAQ), SYNTHETIC BIOLOGICS INC (NYSE American), IBIO INC (NYSE American), INFINITY PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), REGENT PACIFIC (HKEx), ONCOSIL MEDICAL LIMITED (ASX), ORGENESIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), IMMUTEP LTD (ASX), IDERA PHARMACEUTICALS INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), PORT (SET), CIDARA THERAPEUTICS INC (NASDAQ), IMMUNE DESIGN CORP (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), CT ENTERPRISE (HKEx), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), SESEN BIO INC (NASDAQ), INMUNE BIO INC (NASDAQ), AQUINOX PHARMACEUTICALS INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), OTONOMY INC (NASDAQ), VERMILLION INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), OPHTHOTECH CORPORATION (NASDAQ), EVOGENE LTD (NASDAQ), PROTEON THERAPEUTICS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), VACCINEX INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), PHYLOGICA LIMITED (ASX), CATABASIS PHARMACEUTICALS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), ORAGENICS INC (NYSE American), BIONOMICS LTD (ASX), VISTAGEN THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ASTERIAS BIOTHERAPEUTICS INC (NYSE American), IMUGENE LIMITED (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), GENOCEA BIOSCIENCES INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), BIONANO GENOMICS INC (NASDAQ), BIOTRON (ASX), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), ARSANIS INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), EXTRAWELL PHAR (HKEx), CONTRAFECT CORP (NASDAQ), ONCOMED PHARMACEUTICALS INC (NASDAQ), CURIS INC (NASDAQ), SOPHIRIS BIO INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), TRACON PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), ADVAXIS INC (NASDAQ), BIOSINO BIO-TEC (HKEx), CEL-SCI CORP (NYSE American), NOVELION THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), NANOVIRICIDES INC (NYSE American), APTOSE BIOSCIENCES INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), BENITEC BIOPHARMA LTD (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), CAN FITE BIOPHARMA LTD SPON ADR EA REPR 2 ORD SHS (NYSE American), SEELOS THERAPEUTICS INC (NASDAQ), GTX INC (NASDAQ), PROTEOMICS INTL LABORATORIES LTD (ASX), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), VICAL INC (NASDAQ), ISORAY INC (NYSE American), SENESTECH INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), ADALTA LTD (ASX), FIBROCELL SCIENCE INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), REGENEUS LTD (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), PATRYS LIMITED (ASX), RHINOMED LIMITED (ASX), COLLPLANT HOLDINGS LTD SPON ADR EACH REP 50 ORD(POST REV SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NYSE American), LIVING CELL TECHNOLOGIES (ASX), SOLIGENIX INC (NASDAQ), PRANA BIOTECHNOLOGY (ASX), CLEVELAND BIOLABS INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), GENETIC TECHNOLOGIES (ASX), ATYR PHARMA INC (NASDAQ), ANTEO DIAGNOSTICS LIMITED (ASX), GENETIC TECHNOLOGIES SPON ADR EA REPR 150 ORD(POST SPLIT) (NASDAQ), PRANA BIOTECHNOLOGY SPON ADR EA REPR 60 ORD (POST REV SPLIT) (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), VAXART INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), EDGE THERAPEUTICS INC (NASDAQ), CELLMID LIMITED (ASX), AURIS MEDICAL HOLDING AG (NASDAQ), ORTHOCELL LIMITED (ASX), TROVAGENE INC (NASDAQ), OPGEN INC (NASDAQ), BIOCEPT INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), BIOXYNE LIMITED (ASX), ACHIEVE LIFE SCIENCE INC (NASDAQ), ALLIQUA BIOMEDICAL INC (NASDAQ), HAO WEN HLDGS (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), NEURALSTEM INC (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), CYCLACEL PHARMA IN (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), VITAL THERAPIES INC (NASDAQ), MEGASUN (Bursa), CELLECTAR BIOSCIENCES INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), PRECIPIO INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), HISTOGENICS CORP (NASDAQ), NOVITA HEALTHCARE LTD (ASX), XTL BIOPHARMACEUTICALS LTD SPON ADR EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), MEMPHASYS LTD (ASX), HEMISPHERX BIOPHARMA INC (NYSE American), PHIO PHARMACEUTICALS CORP (NASDAQ), MGRC (Bursa), TBG DIAGNOSTICS LTD (ASX), MEDIBIO LIMITED (ASX), STELLAR BIOTECHNOLOGIES INC (NASDAQ), OHR PHARMACEUTICAL INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), PHOSPHAGENICS LTD (ASX), NANOLLOSE LTD (ASX), AMPLIA THERAPEUTICS LTD (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), BIOBLAST PHARMA LTD (NASDAQ), MIDATECH PHARMA PLC SPON ADR EACH REP 2 ORD SHS (NASDAQ), CYTORI THERAPEUTICS INC (NASDAQ), FACTOR THERAPEUTICS LIMITED (ASX), ALCHEMIA LIMITED (ASX), CCP TECHNOLOGIES LTD (ASX), INTELLIPHARMACEUTICS INTL INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), AMPLIPHI BIOSCIENCES CORPORATION (NYSE American), BPH ENERGY LIMITED (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), GENERA BIOSYSTEMS LIMITED (ASX) |